Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Philips Clinical & Medical Affairs Global
- Study ID
- NCT04800094
- Status
- Completed
Conditions
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Investigational Liver Fat Quantification Software — DEVICEAll subjects enrolled in this study will undergo two abdominal ultrasound examinations using the investigational Liver Fat Quantification feature on the Philips EPIQ Ultrasound System. In addition, all subjects will also undergo one MRI-PDFF examination according to the clinical standard of care.
Study Details
This clinical study will involve performing a series of medical imaging procedures of the abdomen using both ultrasound and MRI modalities in subjects at risk for or already diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). The primary objective of this clinical study is to evaluate the clinical feasibility of an investigational ultrasound technique for quantifying liver fat by comparing specific ultrasound-derived biomarkers with the liver fat percentage obtained from MRI Proton Density Fat Fraction (MRI-PDFF) measurements. All subjects enrolled in this study will undergo one investigational abdominal ultrasound examination using the Philips EPIQ Ultrasound System and one MRI PDFF examination according to the clinical standard of care.
Key Dates
- Start date
- Mar 2, 2021
- Status verified
- Sep 2024
- Primary completion
- Dec 13, 2022
- Completion
- Dec 13, 2022
Study Design
- Enrollment
- 30 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Investigational Ultrasound Imaging for Liver Fat Quantification
Primary Outcome Measure
Correlation of the Liver Fat Percentage Reported From MRI-PDFF With Measurements of Hepatorenal Index (HRI) Ultrasound Biomarker for Liver Fat. [ Time Frame: Intra-procedural (1 day) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Fibrosis Lessens After Metabolic SurgeryPHASE4 · Recruiting · Ali Aminian · Phoenix, Arizona
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseasePHASE2 · Not Yet Recruiting · Justin Ryder · Chicago, Illinois
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)PHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- The Olmsted NAFLD Epidemiology Study (TONES)Recruiting · Mayo Clinic · Rochester, Minnesota